🔎 Trials Near Me

Home › Pulmonary Hypertension › North Carolina

Pulmonary Hypertension clinical trials in North Carolina

8 studies for Pulmonary Hypertension are looking for participants at sites in North Carolina.

Cities in North Carolina

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Greensboro
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Southeastern Research Center, Winston-Salem
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University School of Medicine, Durham
  • Pulmonix, LLC, Greensboro
  • and 2 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421

Xenon MRI Pulm Hypertension

  • Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 10, 2026 · NCT04991454

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Carolinas Medical Center, Charlotte
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

129 Xenon Imaging in Patients Treated With Sotatercept

  • Duke University Medical Center, Durham
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Feb 24, 2026 · NCT06351345

Pulmonary Hypertension Association Registry

  • UNC Chapel Hill, Chapel Hill
  • Duke University Medical Center, Durham
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.